article Open AccessTop 1% cited

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

European Heart Journal · 2012 · Vol. 33(13) · pp. 1635–1701

Authors/Task Force Members:✉(Linnaeus University)Joep Perk(Linnaeus University)Guy De Backer(European Society of Cardiology)H. Gohlke(European Society of Cardiology)Ian Graham(European Atherosclerosis Society)Željko Reiner(European Society of Cardiology)Monique VerschurenChristian Albus(European Society of Cardiology)Pascale Benlian(European CanCer Organisation)G. Boysen(European Society of Hypertension)Renata Cífková(European Society of Cardiology)Christi Deaton(European Society of Cardiology)S. Ebrahim(European Association for the Study of Diabetes)Michael Fisher(European Society of Cardiology)Giuseppe Germanò(European Society of Cardiology)Richard HobbsA. Hoes(International Diabetes Federation)S. Karadeniz(European Society of Cardiology)Alessandro Mezzani(European Society of Cardiology)Eva Prescott(European Society of Cardiology)Lars RydénM. Scherer(European Heart Network)Mikko Syvänne(European Society of Cardiology)Wilma J.M. Scholte op Reimer(European Society of Cardiology)Christian Vrints(European Society of Cardiology)David Wood(European Society of Cardiology)José Luis Zamorano(European Society of Cardiology)F Zannad(Linnaeus University)Other experts who contributed to parts of the guidelines:(Linnaeus University)Marie Therese Cooney(Linnaeus University)Jeroen J. Bax(Linnaeus University)H. Baumgartner(Linnaeus University)Claudio Ceconi(Linnaeus University)V. Dean(Linnaeus University)Christi Deaton(Linnaeus University)Robert Fagard(Linnaeus University)Christian Funck‐Brentano(Linnaeus University)David Hasdai(Linnaeus University)A. Hoes(Linnaeus University)Paulus Kirchhof(Linnaeus University)Juhani Knuuti(Linnaeus University)Philippe Kolh(Linnaeus University)Theresa A. McDonagh(Linnaeus University)Bruno Moulin(Linnaeus University)Bogdan A. Popescu(Linnaeus University)Z. Reiner(Linnaeus University)U Sechtem(Linnaeus University)P. A. Sirnes(Linnaeus University)Michał Tendera(Linnaeus University)Adam Torbicki(Linnaeus University)A. Vahanian(Linnaeus University)Stephan Windecker(Linnaeus University)Document Reviewers:(Linnaeus University)Christian Funck‐Brentano(Linnaeus University)P. A. Sirnes(Linnaeus University)Victor Aboyans(Linnaeus University)Eduardo Alegría Ezquerra(Linnaeus University)Colin BaigentCarlos Brotons(Linnaeus University)G. Burell(Linnaeus University)Antonio Ceriello(Linnaeus University)Johan De SutterJ. Deckers(Linnaeus University)Stefano Del Prato(Linnaeus University)H.‐C. Diener(Linnaeus University)Donna Fitzsimons(Linnaeus University)Zlatko Fras(Linnaeus University)Rainer Hambrecht(Linnaeus University)Piotr JankowskiU Keil(Linnaeus University)Mike Kirby(Linnaeus University)Mogens Lytken Larsen(Linnaeus University)Giuseppe ManciaAthanasios ManolisJohn J.V. McMurray(Linnaeus University)A. Pajak(Linnaeus University)Alexander Parkhomenko(Linnaeus University)Loukianos Rallidis(Linnaeus University)Fausto Rigo(Linnaeus University)Evangelista Rocha(Linnaeus University)Luís M. Ruilope(Linnaeus University)Enno T. van der Velde(Linnaeus University)Diego Vanuzzo(Linnaeus University)Margus Viigimaa(Linnaeus University)Massimo VolpeOlov WiklundC. Wolpert

View via DOI Full-text PDF

Abstract

C-reactive protein CURE Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD cardiovascular disease DALYs disability-adjusted life years DBP diastolic blood

Cardiac Health and Mental Health Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular DiseasesMedicineClinical PracticeTask forceDiseaseClopidogrelAnginaIntensive care medicineCardiovascular healthCardiologyInternal medicine

MeSH terms

Smoking PreventionAdultAgedAntihypertensive AgentsBlood PressureCardiologyCardiovascular AgentsCardiovascular DiseasesChronic DiseaseDelivery of Health CareDiabetes Mellitus, Type 2Diabetic AngiopathiesDiagnostic ImagingDietDrug Combinations

Citations

8,506

FWCI

429.42

field-weighted impact

References

869

Percentile

100%

vs. same field & year

Citations per year

Cited by